Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS

B Yamout1, M Sahraian2, S Bohlega3

  • 1Nehme and Therese Tohme MS Center, American University of Beirut Medical Center, Beirut, Lebanon.

Insights

Updated guidelines are essential for diagnosing and treating multiple sclerosis (MS) due to new criteria and therapies. This review offers practical recommendations for MS diagnosis and management, emphasizing evidence-based approaches.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Evolving diagnostic criteria and novel therapies necessitate updates to multiple sclerosis (MS) management.
  • Current diagnostic and treatment algorithms require revision to reflect advancements in MS care.

Purpose of the Study:

  • To provide updated, evidence-based recommendations and algorithms for the diagnosis and treatment of MS.
  • To guide clinicians in managing various MS phenotypes, including radiologically isolated syndrome, clinically isolated syndrome, relapsing-remitting MS, and progressive MS.

Main Methods:

  • Review of scientific evidence supporting diagnostic criteria and therapeutic interventions for MS.
  • Development of practical algorithms for MS diagnosis and treatment selection.

Main Results:

  • The diagnosis of MS requires integrating clinical and paraclinical data to establish dissemination in space and time, while excluding mimics.
  • Differential diagnosis should be guided by clinical and laboratory red flags to optimize testing.
  • Guidelines cover treatment strategies for acute relapses and different MS disease courses.

Conclusions:

  • Revised diagnostic and treatment algorithms are crucial for optimal multiple sclerosis patient care.
  • Evidence-based recommendations support the selection of appropriate MS therapies to maximize patient benefit.
  • Clinical experience and scientific evidence form the basis for these updated MS management guidelines.